Living Well: Sorting Out the Approach to Relapse
September 09, 2019
Double-click on the image above to view a replay of the teleconference.
In this “Living Well with Myeloma” Teleconference, IMF Chairman of the Board Dr. Brian G.M. Durie will discuss:
- what treatments you should consider if your myeloma has relapsed, with a focus on the latest FDA-approved drugs.
- how to individualize treatment based on a patient’s prior therapies, the length of the onset of relapse, FiSH genetic-risk status, age, and frailty score.
- the latest clinical trials, in particular, immune therapies.
We thank our sponsors for supporting this educational program:
Celgene, and Takeda Oncology